TechCrunch Spotlights Gallant’s Breakthrough Approach to Pet Stem Cell
July 10, 2025 4:45 AM ET
TechCrunch covered Gallant’s Series B funding round in a July 2025 feature, highlighting the promise of ready-to-use, allogeneic stem cell therapies in veterinary medicine.
From TechCrunch
Ready-made stem cell therapies for pets could be coming
Gallant is redefining veterinary medicine with ready-to-use stem cell therapies that reduce inflammation, restore function, and fit seamlessly into everyday practice.
-
10865 Road to the Cure, Ste 101
San Diego, CA 92121 -
+1-855-442-5526
-
-
